CYP cynata therapeutics limited

CYP Price Target post MSB FDA approval., page-14

  1. 9,066 Posts.
    lightbulb Created with Sketch. 7848

    You are trying to discuss with a poster who thinks himself far more intelligent than all (on CYP or MSB) who just finally worked out that Cynata has pretty much been cash flow negative since its IPO in 2007. Sell it. Its doomed. But wasn't in the 17 years prior until now!sneaky.png

    What's funny he is now in agreement with a long term CYP antagonist who has shown himself to repeatedly mis-read cash flow statements, forget R&D rebates, etc, in the continuous FUD he tries to throw at CYP's cash burn (as if investors unaware) and indeed shows similar misunderstanding of the subject with respect to his favoured holding, MSB, on threads therein.
    Last edited by bedger: 04/12/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.010(6.25%)
Mkt cap ! $38.41M
Open High Low Value Volume
16.0¢ 17.5¢ 16.0¢ $42.36K 259.0K

Buyers (Bids)

No. Vol. Price($)
1 19056 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 98496 5
View Market Depth
Last trade - 13.32pm 18/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.